We found no significant differences between omeprazole-treated and untreated EoE cells in the degree of activation of the exogenous eotaxin-3 promoter, showing that omeprazole does not induce modifications to the STAT6 protein that interfere with its function. The gene discussed is STAT6; the disease is eosinophilic esophagitis.